APA (7th ed.) Citation

Alvino Maestri, Su Eun Park, Fiona Fernandes, Zhongyi "Lucy" Li, Yae-Jean Kim, Yun-Kyung Kim, . . . Natalie Banniettis. (2024). A phase 3, single-arm, open-label study to evaluate the safety, tolerability, and immunogenicity of a 15-valent pneumococcal conjugate vaccine, V114, in a 3+1 regimen in healthy infants in South Korea (PNEU-PED-KOR). Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Alvino Maestri, et al. A Phase 3, Single-arm, Open-label Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 15-valent Pneumococcal Conjugate Vaccine, V114, in a 3+1 Regimen in Healthy Infants in South Korea (PNEU-PED-KOR). Taylor & Francis Group, 2024.

MLA (9th ed.) Citation

Alvino Maestri, et al. A Phase 3, Single-arm, Open-label Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 15-valent Pneumococcal Conjugate Vaccine, V114, in a 3+1 Regimen in Healthy Infants in South Korea (PNEU-PED-KOR). Taylor & Francis Group, 2024.